Gesellschaft für Thrombose-
und Hämostaseforschung

53. Jahrestagung 2009 in Wien

GTH 2009

Congress Program: 53rd Annual Meeting - Society of Thrombosis and Haemostasis Research

Tagungsprogramm: 53. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e.V. - GTH

[pdf]Download des gesamten Abstractbandes als .pdf (1,956.5 KB) - So erschienen in Hämostaseologie 01/2009
oder kapitelweise:

[pdf]Plenary Lectures (30.4 KB)

PL1 - Hemostatic Balance in 2009
PL2 - ACCP 2008 and Beyond
PL3 - Hemophilia Treatment of the Future
PL4 - Platelets: Physiology and Diseases

[pdf]Educational Lectures (56.2 KB)

EL1 - Von Willebrand Disease
EL2 - Old and Novel Players in Coagulation
EL3 - New Antithrombotics in Acute Coronary Syndrome
EL4 - Evidence-Based Antithrombotic Therapy in Children
EL5 - Hot Topics in Anticoagulation
EL6 - Peripheral Arterial Occlusive Disease (PAOD)
EL7 - Carriers of Hemophilia
EL8 - Coagulation Testing Prior to and During Surgery
EL9 - Treatment of ITP

[pdf]Symposia (47.0 KB)

SY1 - Venous Thromboembolism
SY2 - Biology and Functions of Platelets
SY3 - Mechanisms of Vascular Disease
SY4 - Inflammation in the Vessel Wall
SY/FC5 - Pediatric Session
SY6 - Hot Topics in Vascular Biology
SY7 - Hemostasis in Major Surgery
SY8 - Chemotherapy Induced Thrombosis
SY9 - Microparticles in Hemostasis and Thrombosis

[pdf]Free Communications (134.3 KB)

FC1 - Cytokine and Cell Signaling
FC2 - Coagulation Factors – New Insights from the Benchmark
SY/FC5 - Pediatric Session
FC3 - Epidemiology of Thrombosis
FC4 - Clinical Research in Hemorrhagic Disorders
FC5 - Understanding Platelet Structure and Biology
FC6 - Basic Research in Hemorrhagic Disorders
FC7 - Thrombosis and Atherosclerosis
FC8 - Research in Platelet-associated Prothrombotic Disorders
FC9 - Pharmacological Modulation of the Platelet and - Coagulation System

Poster Presentations

PP1 - [pdf]Coagulation Factors and Inhibitors (142.5 KB)

PP1.1 - Laboratory Methods and Experimental Models
PP1.2 - Thrombin and Thrombin Receptors
PP1.3 - Tissue Factor,TFPI, Factor VII
PP1.4 - Other Coagulation Factors and Coagulation Factor Inhibitors

PP2 - [pdf]Fibrinolysis and Fibrinogen (35.8 KB)

PP3 - [pdf]Hemorrhagic Disorders (198.1 KB)

PP3.1 - Hemophilia
PP3.2 - Von Willebrand Disease
PP3.3 - Other Congenital Bleeding Disorders
PP3.4 - ITP
PP3.5 - Other Acquired Bleeding Disorders
PP3.6 - Perioperative Hemostasis

PP4 - [pdf]Platelets (137.4 KB)

PP4.1 - Platelet Biology
PP4.2 - Platelet Receptors
PP4.3 - Platelet Function Tests and Experimental Models
PP4.4 - Heparin Induced Thrombocytopenia
PP4.5 - TTP/HUS andADAMTS 13
PP4.6 - New Antiplatelet Agents and Drug Design

PP5 - [pdf]Vascular Biology (79.6 KB)

PP5.1 - Animal and Experimental Models
PP5.2 - Atherosclerosis
PP5.3 - Cellular Activation and Signaling
PP5.4 - Endothelial Cells, Extracellular Matrix and Angiogenesis
PP5.5 - Inflammation, Cytokines and Auto-Immunity

PP6 - [pdf]Thrombotic Disorders and Antithrombotic Therapy (179.3 KB)

PP6.1 - Epidemiology and Diagnosis: Cardiovascular Disease
PP6.2 - Epidemiology and Diagnosis: Venous Thromboembolism
PP6.3 - Thrombophilia and Familial Thrombosis
PP6.4 - Hormones, Pregnancy, Women´s Issue
PP6.5 - Thrombotic Disorders in Children
PP6.6 - Preclinical Studies
PP6.7 - Antithrombotics: Clinical Trials